| Effect of CYP3A5* 3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies L Rojas, I Neumann, MJ Herrero, V Bosó, J Reig, JL Poveda, J Megías, ... The pharmacogenomics journal 15 (1), 38-48, 2015 | 175 | 2015 |
| In utero exposure to mycophenolate mofetil: a characteristic phenotype? A Perez‐Aytes, A Ledo, V Boso, P Sáenz, E Roma, JL Poveda, M Vento American Journal of Medical Genetics Part A 146 (1), 1-7, 2008 | 171 | 2008 |
| Mycophenolate mofetil embryopathy: a newly recognized teratogenic syndrome A Perez-Aytes, P Marin-Reina, V Boso, A Ledo, JC Carey, M Vento European journal of medical genetics 60 (1), 16-21, 2017 | 87 | 2017 |
| SNPs and taxane toxicity in breast cancer patients V Bosó, MJ Herrero, A Santaballa, L Palomar, JE Megias, H De La Cueva, ... Pharmacogenomics 15 (15), 1845-1858, 2014 | 48 | 2014 |
| Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia JE Megías-Vericat, P Montesinos, MJ Herrero, F Moscardó, V Bosó, ... Leukemia & lymphoma 58 (5), 1197-1206, 2017 | 44 | 2017 |
| Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies JE Megías-Vericat, L Rojas, MJ Herrero, V Bosó, P Montesinos, ... The pharmacogenomics journal 15 (2), 109-118, 2015 | 43 | 2015 |
| Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A> G genotype on tacrolimus dose requirements in liver transplantation LE Rojas, MJ Herrero, V Boso, M Garcia-Eliz, JL Poveda, J Librero, ... Pharmacogenetics and genomics 23 (10), 509-517, 2013 | 39 | 2013 |
| Mycophenolate mofetil during pregnancy: some words of caution M Vento, A Perez Aytes, A Ledo, V Boso, JC Carey Pediatrics 122 (1), 184-185, 2008 | 35 | 2008 |
| Pharmacogenomics and the treatment of acute myeloid leukemia JE Megías-Vericat, P Montesinos, MJ Herrero, V Bosó, ... Pharmacogenomics 17 (11), 1245-1272, 2016 | 33 | 2016 |
| Impact of single nucleotide polymorphisms (SNPs) on immunosuppressive therapy in lung transplantation J Ruiz, MJ Herrero, V Bosó, JE Megías, D Hervás, JL Poveda, J Escrivá, ... International Journal of Molecular Sciences 16 (9), 20168-20182, 2015 | 33 | 2015 |
| Serum adalimumab levels predict successful remission and safe deintensification in inflammatory bowel disease patients in clinical practice M Aguas Peris, V Bosó, B Navarro, MR Marqués-Miñana, G Bastida, ... Inflammatory bowel diseases 23 (8), 1454-1460, 2017 | 31 | 2017 |
| Increased hospital stay and allograft disfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285 V Bosó, MJ Herrero, S Bea, M Galiana, P Marrero, MR Marqués, ... Drug Metabolism and Disposition 41 (2), 480-487, 2013 | 25 | 2013 |
| Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy JE Megías-Vericat, P Montesinos, MJ Herrero, F Moscardó, V Bosó, ... The Pharmacogenomics Journal 18 (2), 301-307, 2018 | 24 | 2018 |
| Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment JE Megías-Vericat, P Montesinos, MJ Herrero, F Moscardó, V Bosó, ... Leukemia & lymphoma 58 (12), 2880-2894, 2017 | 23 | 2017 |
| Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population V Bosó, MJ Herrero, E Buso, J Galán, L Almenar, I Sánchez-Lázaro, ... Therapeutic drug monitoring 36 (2), 159-168, 2014 | 23 | 2014 |
| Monitorización de errores de medicación en dispensación individualizada mediante el método del carro centinela M Pérez-Cebrián, I Font-Noguera, L Doménech-Moral, V Bosó-Ribelles, ... Farmacia Hospitalaria 35 (4), 180-188, 2011 | 19* | 2011 |
| A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia JE Megías-Vericat, MJ Herrero, L Rojas, P Montesinos, V Bosó, ... The pharmacogenomics journal 16 (1), 30-40, 2016 | 18 | 2016 |
| Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation I Sánchez-Lázaro, MJ Herrero, C Jordán-De Luna, V Bosó, L Almenar, ... Pharmacogenomics 16 (9), 971-979, 2015 | 17 | 2015 |
| Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis JE Megías-Vericat, L Rojas, MJ Herrero, V Bosó, P Montesinos, ... The pharmacogenomics journal 16 (1), 1-2, 2016 | 13 | 2016 |
| Tigecycline: a new treatment choice against Acinetobacter baumannii V Boso-Ribellesik, E Roma-Sanchezl, J Carmenaz, C Cáceres, D Bautista Frontiers in Anti-Infective Drug Discovery 1, 251, 2011 | 13 | 2011 |
Salvador F AliñoProfesor, universidad de ValenciaVerified email at uv.es
